Healthcare Sales & Marketing Network News: The Medicines Company

Searching News Database: The Medicines Company

HSMN NewsFeed - 12 Dec 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Devices Radiology Venture Capital Personnel

HSMN NewsFeed - 23 Apr 2018
Clarus Appoints Former Ariad CEO Paris Panayiotopoulos as Operating Partner and Member of its Investment Team
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 26 Apr 2017
John Tucker appointed as Chief Executive Officer of scPharmaceuticals
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 9 Jan 2017
The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Nov 2016
The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2016
Federal Circuit Rules for The Medicines Company in Angiomax(R) (bivalirudin) Patent Litigation
Biopharmaceuticals Cardiology Litigation

HSMN NewsFeed - 16 May 2016
The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions

HSMN NewsFeed - 20 Jan 2016
Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team, Adds Two Drug Development Executives
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Jan 2016
Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 31 Aug 2015
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 30 Jul 2014
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2014
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2014
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Dec 2013
European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company's Cangrelor
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 6 Dec 2013
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER(TM) Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 4 Dec 2013
The Medicines Company Acquires Rempex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional

HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 4 Jun 2013
The Medicines Company Signs Agreement to Acquire ProFibrix
Biopharmaceuticals Surgery Mergers & Acquisitions

HSMN NewsFeed - 8 Feb 2013
The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)
Biopharmaceuticals Surgery Licensing Distribution

HSMN NewsFeed - 12 Dec 2012
The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 12 Dec 2012
The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Dec 2012
Savient Announces the Election of Robert G. Savage to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Jun 2012
Cees Heiman Joins The Medicines Company to Lead Europe and Middle East Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
Biopharmaceuticals Litigation

HSMN NewsFeed - 6 Apr 2010
Cempra Announces Expansion of Clinical Management Team to Advance Leading Antibacterial Clinical Programs TAKSTA(TM) and CEM-101
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Mar 2010
The Medicines Company Expands a Nationwide Recall for Certain Lots of Cleviprex(R) That May Contain Particulate Matter
Biopharmaceuticals Product Recall

HSMN NewsFeed - 4 Jan 2010
The Medicines Company Files Additional Patent Infringement Lawsuits
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 22 Dec 2009
The Medicines Company Acquires ApoA-I Milano From Pfizer
Biopharmaceuticals Licening

HSMN NewsFeed - 1 Dec 2009
The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 2 Oct 2009
The Medicines Company Announces the Resignation of Its Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology

HSMN NewsFeed - 10 Aug 2009
The Medicines Company Responds to Incorrect News Reports
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Jul 2009
The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jun 2009
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Feb 2009
The Medicines Company Completes Acquisition of Targanta Therapeutics Corporation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2009
The Medicines Company to Acquire Targanta Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Aug 2008
New Publication Shows Cleviprex(TM) is Safe and Effective for Treatment of Acute, Severe Hypertension
Biopharmaceuticals

HSMN NewsFeed - 5 Aug 2008
Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The Medicines Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2008
The Medicines Company Acquires CU-2010 and Curacyte Discovery GmbH
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2008
TVM Capital Welcomes The Medicines Company in The European Market Through the Acquisition of Curacyte Discovery GmbH
Biopharmaceuticals Venture Capital Mergers & Acquisitions

HSMN NewsFeed - 4 Aug 2008
The Medicines Company's Cleviprex(TM) Receives FDA Approval
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Jul 2008
New Publication Shows Cleviprex(TM) is Effective for Rapid Treatment of Acute Hypertension After Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Jun 2008
Controlling Perioperative Hypertension with Cleviprex Reduces Risk of Heart Attack and of Death Following Cardiac Surgery, According to New Analyses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Jun 2008
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Biopharmaceuticals

HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 May 2008
Biogen Idec Celebrates 30 Years of Transforming Discovery into Care
Biopharmaceuticals

HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 4 Feb 2008
Steven Steinhubl, MD, Joins The Medicines Company as Global Vice President, Thrombosis
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 7 Jan 2008
James Ferguson, MD Joins The Medicines Company as Vice President, Global Medical, Surgical and Critical Care
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2007
Pacira Pharmaceuticals Names David M. Stack CEO and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Oct 2007
Warburg Pincus Completes Acquisition of Bausch & Lomb
Devices Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2007
Cleviprex(TM) (Clevidipine Butyrate) Rapidly Reduced Blood Pressure and Maintained Control in Study of Patients with Acute Hypertension
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Oct 2007
Improved Perioperative Blood Pressure Control Associated with Reduced Risk of Kidney Dysfunction in Cardiac Surgery Patients
Biopharmaceuticals Cardiology Surgery

HSMN NewsFeed - 24 Sep 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 21 Sep 2007
Bausch & Lomb Shareholders Approve Merger with Affiliates of Warburg Pincus
Devices Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 14 Sep 2007
FDA Accepts NDA Filing for Cleviprex(TM) (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension
Biopharmaceuticals

HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Jul 2007
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 May 2007
Bausch & Lomb Enters into Merger Agreement with Warburg Pincus
Devices Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 16 Apr 2007
Panacos Announces New Board Member
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2007
The Medicines Company Elects Hiroaki Shigeta to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2007
Pivotal Phase III Findings With Investigational Drug Cleviprex(TM) (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Mar 2007
Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Mar 2007
The Medicines Company Products Angiomax(R) (bivalirudin) and Cleviprex(TM) (clevidipine) Featured in Three Late Breaking Trials at American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Feb 2007
The Medicines Company Supports Landmark Patient Observational Study and Clinical Survey on Acute Severe Hypertension
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Feb 2007
Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
The Medicines Company's Cleviprex(TM) (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives
Biopharmaceuticals

HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Oct 2006
Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2006
The Medicines Company Commences Phase III Clinical Trial of Cangrelor
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 11 Sep 2006
The Medicines Company Completes Clevidipine Phase III Safety Trials and Initiates Phase III Severe Hypertension Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Jul 2006
Amicus Therapeutics Adds Glenn P. Sblendorio to Board of Directors
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 41

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 41 additional stories matching:
The Medicines Company
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.